Wu Zhong
Central South University(CN)Wuhan Polytechnic University(CN)Guangdong University of Foreign Studies(CN)Academy of Military Medical Sciences(CN)Hunan Cancer Hospital(CN)National Institutes for Food and Drug Control(CN)Institute of Pharmacology(CZ)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Mosquito-borne diseases and control, Viral Infections and Vectors, Influenza Virus Research Studies
Most-Cited Works
- → Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro(2020)7,329 cited
- → Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods(2020)2,451 cited
- → Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission(2020)2,327 cited
- → Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro(2020)2,179 cited
- → Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study(2020)1,396 cited
- → The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro(2020)338 cited